Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’
Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
In early December, the Trump administration issued its National Security Strategy, a 33-page document required by law that has been......
Over recent years, trust in elections among the American electorate has been in decline. The Trump Administration has expressed a......
